A Gallbladder Carcinoma Patient With Pseudo-Progressive Remission After Hydrogen Inhalation.

The publication “A Gallbladder Carcinoma Patient With Pseudo-Progressive Remission After Hydrogen Inhalation.” is organized in H2HUBB under the research focus hydrogen inhalation cancer supportive study 31695424. The publication is cited as Chen J, Mu F, Lu T, Ma Y, Du D, Xu K, OncoTargets and therapy, 2019. This uncontrolled human study examined A Gallbladder Carcinoma Patient With Pseudo-Progressive Remission After Hydrogen Inhalation. The abstract describes Human participants; hydrogen delivered as hydrogen inhalation; reported duration 10 months. The abstract reports: This is the first report of pseudo-progression followed by sustained remission after hydrogen inhalation. This phenomenon is similar to the pseudo-progression-remission pattern that occurs…. This is an automated editorial draft based on the abstract and requires source review before publication.

Hydrogen inhalation cancer supportive study 31695424 overview

Hydrogen therapy has been reported to convert exhausted programmed cell death receptor (PD-1)+CD8+ T cells to PD-1-CD8+ T cells, in advanced colorectal cancer patients,… Because this is human clinical evidence, relevance depends on participant selection, controls, sample size, treatment duration, adherence, outcome measures, and replication.

Study design and hydrogen intervention

Publication type: Uncontrolled human study. Evidence type: Human clinical evidence. Research model or population: Human participants. Blinding: Unknown. Control status: Unknown.

Delivery method: Hydrogen inhalation. Treatment duration: 10 months.

Reported findings and scientific interpretation

For this hydrogen inhalation cancer supportive study 31695424, the study record reports the following: The abstract reports: This is the first report of pseudo-progression followed by sustained remission after hydrogen inhalation. This phenomenon is similar to the pseudo-progression-remission pattern that occurs…

These findings should be interpreted as one piece of evidence rather than as a stand-alone medical conclusion. Results can be influenced by the research model, study design, treatment protocol, sample size, outcome selection, statistical methods, and whether the findings have been independently reproduced.

How this research record was prepared

H2HUBB organizes bibliographic details, study design information, intervention data, outcomes, limitations, and safety notes from the available scientific source. Automated classification supports database organization, but it does not replace critical reading of the complete paper. Source identifiers, evidence labels, and delivery-method fields are retained so readers can verify the record and compare it with related publications. A missing field means the information was unavailable or not reported in the structured source; it should not be treated as a negative finding.

Limitations, safety, and original source

Limitations: The abstract alone may not report all methodological limitations; full-text review is required.

Safety: The abstract did not provide detailed safety or adverse-event information.

This H2HUBB page is an educational research record, not medical advice. Review the original scientific source for the complete methods and results. Continue exploring the H2HUBB Molecular Hydrogen Research Library to compare evidence types, delivery methods, and related topics.